Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL29170907 | 0.95 | SLC22A6 (0.38) | SLC22A6TP53GRIA1 | |
| Propene SCHEMBL28854538 | 0.88 | SLC22A6 (0.34) | SLC22A6 | |
| Maleic Anhydride SCHEMBL9419475 | 0.79 | — | — | |
| SCHEMBL10962258 | 0.78 | TP53 (0.32) | TP53GRIA1 | |
| SCHEMBL1985953 | 0.77 | — | — | |
| SCHEMBL6946806 | 0.77 | — | — | |
| SCHEMBL8527696 | 0.77 | — | — | |
| SCHEMBL8943153 | 0.76 | TP53 (0.31) | TP53GRIA1 | |
| SCHEMBL14955405 | 0.75 | TP53 (0.37) | TP53GRIA1 | |
| SCHEMBL10708540 | 0.75 | SLC22A6 (0.43) | SLC22A6TP53GRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 686 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024255699-A1 | SECONDARY BATTERY AND DEVICE | 蔚来汽车科技(安徽)有限公司 | 2024-12-19 | — | — | WO | claimed |
| WO-2024255698-A1 | SECONDARY BATTERY AND DEVICE | 蔚来汽车科技(安徽)有限公司 | 2024-12-19 | — | — | WO | claimed |
| WO-2024217459-A1 | SECONDARY BATTERY AND APPARATUS | 蔚来汽车科技(安徽)有限公司 | 2024-10-24 | — | — | WO | claimed |
| CN-115518041-B | Ginsenoside irinotecan liposome, and preparation method and application thereof | 厦门本素药业有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115124502-B | Preparation method of propylene disulfonic anhydride | 张家港市国泰华荣化工新材料有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118271603-A | Polyaniline nanoparticle and preparation method thereof | 广东腐蚀科学与技术创新研究院 | 2024-07-02 | — | — | CN | claimed |
| CN-117966296-B | Water treatment filter material and preparation method thereof | 浙江伊诺环保集团股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117966296-A | Water treatment filter material and preparation method thereof | 浙江伊诺环保集团股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117166248-B | Water-dispersible fiber and preparation method thereof | 山东鲁纤建材科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117777341-A | Preparation method of super-hydrophobic copolymer biodiesel catalyst | 福州大学 | 2024-03-29 | — | — | CN | claimed |
| US-6664015-B1 | Diacid, diol, and carbinol carboxy terminated polydimethylsiloxane comonomers with at least one being a sulfonate salt; paints, toners, protective coatings | XEROX CORPORATION | 2003-12-16 | — | — | US | claimed |
| WO-2003009881-A2 | NOVEL TARGETED DELIVERY SYSTEM FOR BIOACTIVE AGENTS | IMARX THERAPEUTICS, INC. (US) | 2003-02-06 | — | — | WO | claimed |
| EP-0894156-A4 | REMOVAL OF ORTHOPHOSPHITE IONS FROM ELECTROLESS NICKEL PLATING BATHS | ATOTECH DEUTSCHLAND GMBH (DE) | 2002-06-26 | — | — | EP | claimed |
| US-20020041898-A1 | Novel targeted delivery systems for bioactive agents | IMARX THERAPEUTICS, INC. | 2002-04-11 | — | — | US | claimed |
| EP-1060750-A2 | Method for treating amyloidosis | Queen's University at Kingston (CA) | 2000-12-20 | — | — | EP | claimed |
| EP-0894156-A1 | REMOVAL OF ORTHOPHOSPHITE IONS FROM ELECTROLESS NICKEL PLATING BATHS | ATOTECH Deutschland GmbH (DE) | 1999-02-03 | — | — | EP | claimed |
| WO-1998021381-A1 | REMOVAL OF ORTHOPHOSPHITE IONS FROM ELECTROLESS NICKEL PLATING BATHS | ATOTECH DEUTSCHLAND GMBH (DE) | 1998-05-22 | — | — | WO | claimed |
| US-5534611-A | Sulfonated and carboxylated aminoethylenephosphonic acid and aminobis (methylene) phosphinic acid | NALCO CHEMICAL COMPANY (US) | 1996-07-09 | — | — | US | claimed |
| EP-0691844-A1 | METHOD FOR TREATING AMYLOIDOSIS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1996-01-17 | — | — | EP | claimed |
| WO-1994022437-A2 | METHOD FOR TREATING AMYLOIDOSIS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1994-10-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020041898-A1 | Novel targeted delivery systems for bioactive agents | BMP2, MMP7, HDGF | SLC22A6 1487/4885TP53 343/4885GRIA1 4054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.